Prophylaxis of hepatitis B infection in solid organ transplant recipients.

about

Current hepatitis B treatment guidelines and future research directions.Immunization after kidney transplantation-what is necessary and what is safe?

P2860

Q30487002-BAEA47E9-3D11-4188-966D-D94776CBEAAE Q38235003-4677D699-0641-4AA8-A695-8933098C3203

P2860

Prophylaxis of hepatitis B infection in solid organ transplant recipients.

Item

http://www.wikidata.org/entity/Q36886518

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Prophylaxis of hepatitis B infection in solid organ transplant recipients.

@en

type

Item

label

Prophylaxis of hepatitis B infection in solid organ transplant recipients.

@en

prefLabel

Prophylaxis of hepatitis B infection in solid organ transplant recipients.

@en

P1476

Prophylaxis of hepatitis B infection in solid organ transplant recipients.

@en

P2093

A Benedict Cosimi

http://www.w3.org/2001/XMLSchema#string

James F Markmann

http://www.w3.org/2001/XMLSchema#string

Karin L Andersson

http://www.w3.org/2001/XMLSchema#string

Martin Hertl

http://www.w3.org/2001/XMLSchema#string

Raymond T Chung

http://www.w3.org/2001/XMLSchema#string

Savio John

http://www.w3.org/2001/XMLSchema#string

P2860

Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions

The option of HBIG-free prophylaxis against recurrent HBV

Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease.

Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy.

P304

309-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756283X13487942

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Camille Nelson Kotton

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23814610

http://www.w3.org/2001/XMLSchema#string

P932

3667476

http://www.w3.org/2001/XMLSchema#string

Prophylaxis of hepatitis B infection in solid organ transplant recipients.

about

P2860

P2860

Prophylaxis of hepatitis B infection in solid organ transplant recipients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932